Biotech firm gets grant for ulcer cure
By Brielle Friedman | February 23CytoSolv Inc., a biotech startup in Providence, received $500,000 in seed-stage funding from the Slater Technology Fund, a Rhode Island capital fund committed to supporting technology-based businesses. CytoSolv is in the process of testing an acellular treatment for healing diabetic ulcers. The product ...